Cargando…
Kinase Inhibitory Activities and Molecular Docking of a Novel Series of Anticancer Pyrazole Derivatives
A series of novel 1,3,4-triarylpyrazoles containing different heterocycles has been prepared, characterized and screened for their in vitro antiproliferative activity against HePG-2, MCF-7, PC-3, A-549 and HCT-116 cancer cell lines. The biological results revealed that compound 6 showed the highest...
Autores principales: | Nossier, Eman S., Abd El-Karim, Somaia S., Khalifa, Nagy M., El-Sayed, Ali S., Hassan, Emad S. I., El-Hallouty, Salwa M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321587/ https://www.ncbi.nlm.nih.gov/pubmed/30477238 http://dx.doi.org/10.3390/molecules23123074 |
Ejemplares similares
-
Biological Validation of Novel Polysubstituted Pyrazole Candidates with in Vitro Anticancer Activities
por: Fahmy, Hoda H., et al.
Publicado: (2016) -
Synthesis and biological evaluation of new derivatives of thieno-thiazole and dihydrothiazolo-thiazole scaffolds integrated with a pyrazoline nucleus as anticancer and multi-targeting kinase inhibitors
por: Othman, Ismail M. M., et al.
Publicado: (2021) -
Design, Synthesis and Docking Studies of Novel Macrocyclic Pentapeptides as Anticancer Multi-Targeted Kinase Inhibitors
por: Amr, Abd El-Galil E., et al.
Publicado: (2018) -
Anticancer evaluation and molecular modeling of multi-targeted kinase inhibitors based pyrido[2,3-d]pyrimidine scaffold
por: Elzahabi, Heba S. A., et al.
Publicado: (2018) -
Design and Synthesis of Novel Pyrazole-Substituted Different Nitrogenous Heterocyclic Ring Systems as Potential Anti-Inflammatory Agents
por: Nossier, Eman S., et al.
Publicado: (2017)